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Objective. The aim of this in vitro study was to assess the substantive antimicrobial activity of different medicaments
in human root dentin.
Study design. Canals of 98 roots were enlarged to standard size and medicated for 7 days with the following: (1) 2%
chlorhexidine (CHX) gel, (2) 0.2% CHX gel, (3) 2% CHX solution, (4) Ca(OH)2, (5) Ca(OH)2  0.2% CHX gel, (6) 2%
CHX solution  a 25% CHX-containing controlled-release device, (7) saline, and (8) gel vehicle. After medication,
canals were inoculated with Enterococcus faecalis for 21 days. Dentin samples were collected with Gates-Glidden
burs into brain heart infusion broth, and bacterial growth was assessed with spectrophotometric analysis of optical
density after 72 hours of incubation.
Results. Mean optical densities were significantly lower for groups with 2% CHX (1, 3, and 6) when compared with
those of the controls (P  .05, analysis of variance with the Tukey test). Other groups did not differ significantly from
the controls.
Conclusions. Canal dressing for 1 week with 2% CHX may provide residual antimicrobial activity against E faecalis.
(Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:240-5)
One of the concerns regarding the outcome of endodon-
tic treatment is the potential for root canal reinfection
after treatment, even if the canal was thoroughly disin-
fected before root filling. Reinfection and consequent
treatment failure can occur because of regrowth of
residual bacteria that survived the treatment proce-
dure.1-3 Also, because secondary caries or leakage may
allow later ingress of new bacteria into root canals,4 it
is desirable to develop therapeutic measures that would
effectively prevent reinfection and, thus, potentially
improve the outcome of endodontic treatment.
One treatment protocol that has been suggested to
prevent root canal reinfection in vitro is medication
with chlorhexidine gluconate (CHX).5 CHX is a broad-
spectrum antibacterial agent6,7 whose antimicrobial ef-
ficacy equals that of the conventional root canal irrig-
ants and medicaments.8-17 Unlike the conventional
medicaments, the positively charged molecules of CHX
can adsorb onto the dentin6 and prevent microbial col-
onization on the dentin surface for some time.18 An
antimicrobial effect sustained over time is referred to as
substantive antimicrobial activity (SAA).19 When CHX
is used as a root canal irrigant, the antimicrobial effect
is short-lived.5,20 For long-term SAA to be achieved,
the dentin must be exposed to CHX for a longer time
than that afforded by irrigation.21-23
A number of studies have demonstrated CHX-af-
fected SAA in bovine root dentin. Komorowski et al21
used 0.2% CHX solution for 7 days. Heling et al23 used
a biodegradable controlled-release device (CRD) for
the delivery of CHX for 7 days, whereas Lenet et al24
used both a nondegradable CRD and a gel vehicle for 7
days. The root canals of bovine teeth are considerably
larger than those of human teeth; therefore, the volume
of CHX available to interact with the dentin is rela-
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tively large. To better simulate the potential clinical
application of CHX, this study sought to assess the
efficacy of CHX in different concentrations and modes
of applications with respect to providing SAA in the
root dentin of human teeth.
MATERIAL AND METHODS
Preparation of specimens
Ninety-eight freshly extracted human teeth were im-
mersed in 0.5% NaOCl for 24 hours to remove organic
debris and disinfect the surface. The crowns and apices
of the teeth were resected with a water-cooled, rotating
diamond saw to produce uniform, 6-mm-long speci-
mens. Cementum was removed from the surface of the
specimens by using a sanding wheel mounted in a
Dremel Multipro Rotary Tool model #395 (Dremel,
Racine, Wis) at 300 rpm to establish an approximate
external diameter of 4 mm. The root canal of each
specimen was enlarged throughout with a #3 Gates-
Glidden drill to standardize its internal diameter. To
prevent dehydration, specimens were kept in water
during all procedures. Organic and inorganic debris
was removed by immersing the specimens in an ultra-
sonic bath of 17% EDTA followed by 0.5% NaOCl,
each for 5 minutes. The efficacy of the described pro-
cedure in the total removal of the smear layer has been
demonstrated elsewhere.21,25
The root specimens were placed in test tubes con-
taining brain heart infusion (BHI) broth (Difco Labo-
ratories, Baltimore, Md), autoclaved for 30 minutes at
121°C, and incubated for 24 hours at 37°C to confirm
sterility by the absence of turbidity. The sterilized spec-
imens were immersed in an ultrasonic bath of fresh BHI
broth for 15 minutes to enhance penetration of the broth
into the dentinal tubules. They were blotted dry with
sterile paper, coated externally with 2 layers of nail
varnish, and mounted in the bottom of a sterile Petri
dish with sticky wax.
Medication
The specimens were randomly divided into 6 exper-
imental groups (1-6) and 2 control groups (7 and 8).
Under aseptic conditions, the root canals were medi-
cated with one of the following (Table): group 1, 2%
CHX gel; group 2, 0.2% CHX gel; group 3, 2% CHX
aqueous solution; group 4, calcium hydroxide powder
mixed with vehicle gel; group 5, calcium hydroxide
mixed with 0.2% CHX gel; group 6, 2% CHX solution
with a single 25% CHX-containing CRD; group 7,
sterile saline; and group 8, vehicle gel alone. The pre-
pared canal of each specimen was injected with the
intracanal medicament until full (0.1 mL). The CRD
consisted of a core of CHX dissolved in water-perme-
able polymers, encased in nondegradable polymer film
coating formed to resemble a gutta-percha cone. Its
characteristics have been described in detail else-
where.26
After placement of the medications or control solu-
tions, the specimens were coronally sealed with wax
and incubated at 37°C for 7 days. Once placed, the
medications were not replenished.
Inoculation
At the end of the medication period, the medications
were washed out and the canals were rinsed with 10 mL
of sterile saline and blotted dry with sterile paper
points. An inoculum of Enterococcus faecalis (ATCC
29212) grown overnight in BHI broth and adjusted to
0.5 turbidity reading of the McFarland scale (1.5  108
bacteria/mL)27 was then injected into each canal. The
inoculated specimens were incubated at 37°C for 21
days. Fresh inoculum was added every other day, and
sterile BHI broth was added daily to keep the canals
full. Supernatant samples were cultured weekly to con-
firm the viability and the purity of the inoculum.
Root dentin sampling
At the end of the inoculation period, each canal was
thoroughly rinsed with 10 mL of sterile saline and
blotted dry with sterile paper points. Two samples of
root dentin were then obtained by enlarging the canal
with sterile Gates-Glidden drills, as follows (Fig 1): the
“inner” sample was obtained with drill #4 to a depth of
0.1 mm from the root canal surface, and the “outer”
sample was then obtained with drill #5 to a depth of 0.2
mm from the root canal surface. Each dentin sample
was collected into a separate sterile vial containing 3
mL of sterile fresh BHI broth and was incubated at
37°C for 72 hours to allow the growth of any bacteria
Table. Description of the groups
Group n Medication Vehicle
1 15 2% CHX CMC gel
2 15 0.2% CHX CMC gel
3 15 2% CHX Water
4 15 Ca(OH)2 CMC gel
5 15 Ca(OH)2  0.2% CHX CMC gel
6 13 CRD  2% CHX CRD  water
7 5 Control Water
8 5 Control CMC gel
CHX, Chlorhexidine gluconate 20% BP lot #9915, Wiler Fine Chemicals,
London, Ontario, Canada.
Ca(OH)2, Calcium hydroxide USP lot #196415/8381, BDH Fine Chemicals,
Toronto, Ontario, Canada.
CRD, An experimental controlled-release device containing 25% CHX by
weight, University of Toronto, Ontario, Canada, with 2% CHX solution.
CMC, Methylcellulose 4000 USP lot #35933, Wiler Fine Chemicals,
London, Ontario, Canada.
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harbored in the dentin. When the broth became turbid,
indicating bacterial growth, it was cultured to ensure
the purity of E faecalis.
Data analysis
After 72 hours, the optical density (OD) of the broth
was read by using an Ultrospec III spectrophotometer
(Pharmacia LKB Biochrom Ltd, Cambridge, England)
at a 600-nm wavelength. OD readings were adjusted to
the OD value of fresh, sterile BHI broth as baseline.
Within each group, the mean OD values for the inner
and outer samples were compared with those of the
paired-samples t test. Repeated-measures analysis of
variance, taking into account the paired nature of sam-
ple collection, was used to analyze the differences
among the groups. The Tukey post hoc test was then
used to compare individual groups, separately for the
inner and outer samples. Statistical tests were 2-tailed
and interpreted at the 5% significance level.
RESULTS
The OD values observed for the inner and outer
samples of all groups are graphically plotted in Fig 2, A
and B, respectively. In group 3 (2% CHX solution), the
inner samples had significantly lower OD values than
the outer samples (P  .04). In group 4 (calcium
hydroxide with vehicle gel) the inner samples had sig-
nificantly higher OD values than the outer samples
(P  .03). In all other groups, the OD values of the
inner and outer samples did not differ significantly.
Samples from groups 1, 3, and 6 (2% CHX in gel,
solution, and CRD, respectively) had significantly
lower OD values than those from groups 7 and 8
(positive controls)Cfor both the inner and the outer
samples. Samples from groups 4 and 5 (calcium hy-
droxide without and with 0.2% CHX, respectively) did
not significantly differ from those from groups 7 and 8.
The outer samples from group 2 (0.2% CHX gel) had a
significantly lower OD value than did those from
groups 7 and 8, but this value was not different from all
the other groups; however, the inner samples did not
differ significantly from all the other groups.
DISCUSSION
The experimental model used in this study was
adapted from that established by Ørstavik and Haa-
pasalo25,28 for the study of infection and disinfection of
the dentinal tubules. That original model has been
modified by several researchers to adapt it to the as-
sessment of antimicrobial activity in root dentin after
medication.21-23 In the present study, the model was
further modified by adapting it to extracted human teeth
rather than the previously used bovine incisors. This
modification was considered appropriate because of the
marked difference in diameter between the canals of
bovine and human teeth. The standardized bovine ca-
nals in some of the previous studies are more than 3
mm in diameter,24 which is more than 3-fold that of the
standardized canals in this study. Accordingly, the ca-
nal volume of the bovine root specimen is almost
10-fold larger than that of the human root specimen of
the same length. Because SAA imparted by CHX is
known to depend on the amount of CHX molecules
available to interact with the dentin,7 the “extra large”
canals and quantity of CHX in the bovine root speci-
mens may not be relevant to the possible clinical ap-
plication of CHX in the usual canals of human teeth.
Particularly, immersion of a single CRD in a large
amount of CHX may misrepresent the clinical applica-
tion of the CRD as it was intended.
E faecalis was chosen for the inoculum in this study
Fig 1. Schematic representation of the circumferential sam-
pling of the dentin. Root canals initially standardized with #3
Gates-Glidden (GG) drill were enlarged with #4 (inner sam-
ple) and #5 (outer sample) drills, and the dentin shavings
were collected for analysis of bacterial growth.
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because it is considerably resistant to the common
intracanal medication with calcium hydroxide25,29,30
and frequently associated with persistent disease after
endodontic treatment.3,31-33 Because alternative thera-
peutic modalities that are effective against E faecalis
are desirable,9 the use of this particular microbe to test
potential therapeutic modalities is appropriate. In addi-
tion, E faecalis is a nonfastidious microbe that is rela-
tively easy to culture and it has been implemented
successfully in most studies by using the original mod-
el.21-25
A period of 21 days was selected for the assessment
of SAA imparted by CHX, as in our previous stud-
ies.21,24 Clearly, this period can not be considered “long
term” where the lifetime of a tooth is concerned; how-
ever, it is 3 times longer than that tested by other
researchers.22,23,25 It does represent an attempt to study
SAA over longer periods of time.
The specimens were treated for 1 week with a variety
of medications; then, the ability of E faecalis to colo-
nize the root dentin was measured to assess any anti-
microbial activity imparted to the root dentin. Of the
various experimental and control medications, only
those containing 2% CHX demonstrated resistance to
microbial colonization significantly greater than that of
the positive controls. This finding confirms the CHX–
imparted SAA in root dentin documented by other
researchers.21,24 In fact, it goes further to demonstrate
the dependence of SAA on the concentration of CHX,
as suggested by Komorowski et al.21 Because SAA
depends on the amount of CHX molecules available to
interact with the dentin, medicating the canal with a
more concentrated CHX should result in increased re-
sistance to microbial colonization. The results of this
study suggest that, in contrast to the large bovine canals
in which 0.2% CHX effectively imparts SAA,21-23 in
the small human canals a higher concentration of CHX
was required to impart a comparable effect.
Calcium hydroxide was also tested in the present
study because of its prevalent clinical application as
intracanal medication. It is known to effectively kill
most endodontic pathogens, with the exception of very
few, such as E faecalis22,25 and Candida albicans.34
Calcium hydroxide combined with 0.5% CHX has been
suggested as an effective killer of C albicans34 and a
potential substitute for the use of calcium hydroxide
alone.34 This premise requires systematic investiga-
tion,34 with SAA being one aspect of it. Because the
Fig 2. Optical density values (mean  SE) in broth incubated with dentin samples from human roots treated with test and control
intracanal medicaments. The bars marked with the same letter did not show statistically significant differences from each other
in the statistical analysis (P  .05). A, Inner samples collected at a depth of 0.1 mm. B, Outer samples collected at a depth of
0.2 mm.
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OD values in both calcium hydroxide groups did not
differ from those of the controls, the results clearly
demonstrate the inability of calcium hydroxide alone or
in combination with 0.2% CHX to impart SAA into
root dentin when it is applied as an intracanal medica-
ment for 1 week. Previous studies have also shown that
calcium hydroxide alone does not impart SAA.21-24
This study assessed 3 modalities of application of
CHX for root canal medication: (1) CHX solution, (2)
CHX gel, and (3) CHX-containing CRD immersed in
CHX solution. The first modality is the easiest to use
clinically, and the results of this study confirm that it
did impart SAA when applied for 1 week. However, the
initial quantity of CHX solution in the canal is limited,
and it is assumed that in clinical application, some of it
will be lost by diffusion. Consequently, the amount of
CHX molecules available may be critically depleted.
Because patients may not return for a subsequent treat-
ment session within 1 week, the intracanal medicament
should posses long-term antimicrobial properties to
prevent root canal contamination for extended periods.
If the CHX solution is depleted, there is a risk that the
canal might remain essentially unprotected against mi-
crobial contamination.
Two percent CHX gel emerged as an effective int-
racanal medicament in our previous study24 and was
again confirmed, in this study, to impart SAA. For an
intracanal medicament to be suitable for clinical appli-
cation, its complete removal from the canal should be
easy to ensure effective sealing of the root filling.35 For
example, there are some concerns regarding the re-
moval of calcium hydroxide paste.35 Similarly, the in-
ability to verify total removal of the CHX gel from the
canal could be a concern24 because further instrumen-
tation before root filling is contraindicated to prevent
loss of the CHX-treated dentin surface. According to a
recent 1-year in vitro leakage study,36 a CHX gel used
to medicate the canals does not appear to interfere with
the seal; however, further studies are required to dis-
miss the concerns regarding gel residue on the canal
walls.
A CHX-containing CRD is intended to replenish the
CHX in the canal and, thus, to sustain a high level of
CHX molecules available for interaction with root den-
tin. Researchers have developed degradable CRDs for
endodontic applications.22,23,37 Those devices are ex-
pected to degrade in the canal over time; however, in
clinical application, it may be challenging to verify
whether they degraded completely or partially. There-
fore, there is a risk that fragments of the CRD might
remain in the canal and interfere with root filling. In
contrast, the removal of the CRD used in this study was
not a concern because of its nondegradable design. In
fact, after 1 week the devices remained intact; there-
fore, they were simply withdrawn from the canal. For
the nondegradable CRD used in this study, the steady
release of CHX molecules from the CRD was con-
firmed over a period of at least 45 days.26 In our
previous study in bovine teeth,24 a single CRD was
immersed in a large volume of saline in each canal; this
method failed to impart SAA. In contrast, in this study
the CRD immersed in 2% CHX solution did impart
SAA as expected.
An advantage of the CRD over the 2% CHX solution
or gel could not be claimed on the basis of this study
because the differences among the groups were not
significant. However, as suggested earlier, further stud-
ies making use of longer application periods of the
medicaments and lengthier bacterial inoculation peri-
ods may help us determine the efficacy of the different
CHX application modalities with respect to imparting
SAA. In vivo experiments in animal models, such as
that for coronal inoculation established by Friedman et
al,4 appear to be the next logical step in the assessment
of the role of CHX and the different application mo-
dalities in imparting clinically meaningful SAA.
The use of OD to measure the results may have had
some effect on the outcome of the study because vari-
ation in the early log phase of growth may result in
some variation in the final readings, especially after the
long growth period (72 hours) used in this study. In
addition, the possible carryover effect of CHX in the
dentin samples may have made an impact on the bac-
terial growth in the broth. Additional culturing of di-
luted broth samples for colony-forming units could
have resulted in more detailed information. However,
the culturing of dilutions for colony-forming units in an
experiment with such a large number of samples (eg,
the 98 used in this study) would have been a laborious
task (requiring at least 196 cultures with only 2 dilu-
tions) and could not be conducted in this study. In
addition, the small variation in the OD readings within
the groups indicates that the variations between indi-
vidual samples were not significant. On the other hand,
the long growth period before OD analyses most likely
reduces the magnitude of the CHX carryover effect on
the results. We, therefore, believe that, despite its short-
comings, this study used analytical methods for that are
sufficient to validate the conclusions drawn.
In this study, the CHX medicaments were tested in
vitro with E faecalis in monoculture. However, end-
odontic diseases are primarily caused by mixed infec-
tions.1 The medicament that is effective against a single
microbe may not necessarily be effective against a
complex microbial flora in vivo. Therefore, further
studies are indicated to appraise the efficacy of CHX
with respect to imparting SAA against other recognized
endodontic pathogens.
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